Qiagen NV has appointed [PERSON_NAME] as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.

[PERSON_NAME], a former CEO of Filtration Group, will replace [PERSON_NAME] at the helm of Qiagen effective Sept. 1, according to a statement [PERSON_NAME] Monday that confirmed a Bloomberg News report.

The leadership change comes as Qiagen evaluates strategic options, including a potential acquisition by private equity firms. [PERSON_NAME] brings extensive experience in industrial and technology sectors, having previously led Filtration Group through significant growth initiatives.

The appointment reflects Qiagen's ongoing efforts to strengthen its position in the molecular testing market while exploring opportunities to maximize shareholder value through a possible transaction. The company has not disclosed further details about the sale process or potential buyers.